Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd has informed BSE that it published an advertisement in 'The Business Standard' (English) and 'The Nirbhaya Vaartha' (Hyderabad) on 31st October 2025. The ad notifies shareholders about a special window, open from 7th July 2025 to 6th January 2026, for re-lodging transfer deeds for physical shares that were originally submitted before the 1st April 2019 deadline but were rejected, returned, or left unprocessed due to document deficiencies. This is being done as per a SEBI circular dated 2nd July 2025. The filing is signed by Whole-time Director Venkateshwarlu Pulluru.
This is a routine compliance disclosure with no direct impact on financials or stock price. Shareholders holding physical share certificates who faced earlier transfer issues now have a limited window (until 6th January 2026) to re-submit their transfer requests for processing.